The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post marketing surveillance study of cabazitaxel (CBZ) in Japanese patients with castration resistant prostate cancer (CRPC) in real world settings.
 
Hideyasu Matsuyama
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Janssen; Sanofi
Speakers' Bureau - Sanofi
 
Nobuaki Matsubara
Consulting or Advisory Role - Janssen; Sanofi
Research Funding - Bayer Yakuhin (Inst); Chugai Pharma (Inst); Janssen (Inst); MSD (Inst)
 
Tomoyuki Taguchi
Employment - Sanofi; Sanofi (I)
Stock and Other Ownership Interests - Sanofi
 
Takeshi Seto
Employment - Sanofi
 
Kazuhiro Suzuki
Honoraria - Astellas Pharma; AstraZeneca; Daiichi Sankyo; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; Janssen; Takeda
Speakers' Bureau - Astellas Pharma; Daiichi Sankyo; Janssen; Sanofi; Takeda
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Sanofi (Inst); Takeda (Inst)